Stock Analysis
CLOV (CLOV) Stock Analysis
CLOV (CLOV) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
CLOV (CLOV) currently has an AIQ Score of 43/100, indicating a neutral setup. Momentum is the strongest factor at 56/100. Risk is the weakest current factor at 33/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
CLOV at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $4.46 |
| AIQ Score | 43/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $2.23B |
| P/E Ratio (TTM) | -106.17 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $0.05 |
| Revenue (quarter ended 2026-06-30) | $743.17M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 2.49 |
| Volume | 4.65M |
| 52-week range | $1.58-$5.59 |
| RSI 14 | 42.76 |
| 50-Day SMA | $4.50 |
| 200-Day SMA | $3.53 |
| Analyst Price Target | — |
| Next Earnings | — |
CLOV
Low Priority
Relative Laggard
Latest quote
- Momentum56
- Value42
- Quality38
- Risk resilience33
- Sentiment—
CLOV Stock Analysis Summary
CLOV (CLOV) currently has an AIQ Score of 43/100, indicating a neutral setup. Momentum is the strongest factor at 56/100. Risk resilience is the weakest current factor at 33/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, CLOV has AIQ Score of 43/100 with Momentum base of 56/100 and fading Risk resilience at 33/100. Wait for component alignment before adding exposure.
Momentum (56/100) leads while Risk resilience (33/100) lags. This cross-factor spread creates entry timing uncertainty.
Sector · -2.62% stock move · CLOV classified in its covered industry.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is CLOV Bullish or Bearish Right Now?
CLOV currently has a neutral overall setup. Momentum is the strongest factor at 56/100, while Risk Resilience is weakest at 33/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Price is +1.80% above its 50-day SMA.
- - Value is the current constraint at 42/100.
- - Risk Resilience is weak at 33/100.
- - Technical consensus has more sell votes than buy votes (23 vs 13).
Current Consensus
CLOV's Technical Analysis Consensus is currently Sell, with 13 buy, 9 neutral, and 23 sell votes. CLOV's 14-day RSI is 42.76, which places the stock in a weaker momentum range. CLOV's beta is 2.49, indicating greater market sensitivity than the broad market.
What Changed in CLOV?
The largest recent change in CLOV is Momentum moving down by 15.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the CLOV Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
CLOV Decision Framework
Public evidence layers, setup checks, and risk context for CLOV.
CLOV (CLOV) Stock Analysis
CLOV has an AIQ Score of 43/100 in a Neutral regime. Momentum is strongest at 56/100. Beta is not shown in the current snapshot. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | CLOV is in a Neutral AIQ regime with score 43/100. |
| Signal Conflict | The primary conflict is that momentum leads at 56/100 while risk lags at 33/100. |
| Factor Evidence | Momentum 56/100 · Value 42/100 · Quality 38/100 · Risk 33/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 56/100.
Momentum is 56/100 and RSI (14) is 42.8.
CLOV is in a Neutral regime at 43/100.
Risk factor is 33/100 and annual volatility 62.07%.
Current conflict: momentum leads at 56/100 while risk lags at 33/100.
CLOV Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
CLOV Fundamentals
CLOV valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
CLOV Technical Analysis
CLOV technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
CLOV Stock Catalysts
Track CLOV earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
CLOV Dividend Analysis
CLOV dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
CLOV Financial Data
CLOV revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
CLOV Risk Analysis
CLOV volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
CLOV Stock News
CLOV stock news, market tone, recent headlines, and catalyst context.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching CLOV
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for CLOV
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
CLOV Stock FAQ
What is CLOV stock price today?
CLOV's current stock price is $4.46. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is CLOV bullish or bearish right now?
CLOV's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is CLOV's market cap?
CLOV's market cap is $2.23B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is CLOV's current P/E ratio?
CLOV's current P/E ratio is -106.17 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is CLOV's RSI?
CLOV's 14-day RSI is 42.76 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is CLOV above its 50-day and 200-day moving averages?
CLOV is 1.80% from its 50-day SMA and 29.63% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is CLOV's next earnings date?
CLOV's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does CLOV pay a dividend?
CLOV's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.